Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) belongs to Healthcare sector. Its weekly performance is 11.86%. On last trading day company shares ended up $3.49. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) distance from 50-day simple moving average (SMA50) is 2.34%. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) on May 18, 2015, reported the achievement of key development milestones for its product candidate IMO-9200, an antagonist of Toll-like receptors (TLRs) 7, 8 and 9. Specifically, the company today reported top-line data from a Phase 1 clinical trial of IMO-9200 in healthy subjects and announced the presentation of new preclinical data for IMO-9200 in models of inflammatory bowel disease (IBD) at the 2015 Digestive Disease Week Conference (DDW) in Washington, DC.
Cellectis S.A. (NASDAQ:CLLS) shares moved up 12.46% in last trading session and ended the day at $40.99. Cellectis S.A. (NASDAQ:CLLS) declared that preclinical data on its gene-edited allogeneic CAR T-cells will be presented at the American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting will be held from May 29 to June 2, 2015 in Chicago.
On 27 May, ProAssurance Corporation (NYSE:PRA) shares advanced 0.34% and was closed at $44.50. PRA EPS growth in last 5 year was -0.30%. ProAssurance Corporation (NYSE:PRA) year to date (YTD) performance is -0.78%. Zacks downgraded shares of ProAssurance Corp. (NYSE:PRA) from a hold rating to a sell rating in a research note.
Korea Electric Power Corp. (NYSE:KEP) ended the last trading day at $20.71. Company weekly volatility is calculated as 1.08% and price to cash ratio as 14.76. Korea Electric Power Corp. (NYSE:KEP) showed a weekly performance of -2.82%. A team from the South Korean company chosen to build the UAE’s nuclear reactors will arrive in Abu Dhabi on Wednesday for a three-day workshop on safety and security. Korea Electric Power Corporation (NYSE:KEP) and the Emirates Nuclear Energy Corporation (Enec) will discuss measures taken for the first power plant in Barakah, in the Western Region, which is expected to be in operation in 2017.
General Electric Company (NYSE:GE) shares remains unchanged in last trading session and ended the day at $27.52. GE Gross Margin is 38.30% and its return on assets is 0.30%. General Electric Company (NYSE:GE) quarterly performance is 6.21%. As General Electric Co. (NYSE:GE) seeks to unload most of its finance assets, it is prioritizing the sale of businesses that provide lending to U.S. and European private equity firms, and to healthcare-related businesses, GE Capital’s top executive said on Wednesday.